| Product NDC: | 0781-3132 |
| Proprietary Name: | Methylprednisolone Acetate |
| Non Proprietary Name: | Methylprednisolone Acetate |
| Active Ingredient(s): | 80 mg/mL & nbsp; Methylprednisolone Acetate |
| Administration Route(s): | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; PARENTERAL; SOFT TISSUE |
| Dosage Form(s): | INJECTION, SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0781-3132 |
| Labeler Name: | Sandoz Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040794 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090305 |
| Package NDC: | 0781-3132-71 |
| Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (0781-3132-71) > 1 mL in 1 VIAL, SINGLE-DOSE |
| NDC Code | 0781-3132-71 |
| Proprietary Name | Methylprednisolone Acetate |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (0781-3132-71) > 1 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 0781-3132 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Methylprednisolone Acetate |
| Dosage Form Name | INJECTION, SUSPENSION |
| Route Name | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; PARENTERAL; SOFT TISSUE |
| Start Marketing Date | 20090305 |
| Marketing Category Name | ANDA |
| Labeler Name | Sandoz Inc |
| Substance Name | METHYLPREDNISOLONE ACETATE |
| Strength Number | 80 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |